{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/159947010"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Other factors leading to longer clinical development include: the complex nature of the biology underlying childhood cancers; the difficulty of identifying targets suitable for drug treatment; a lack of long-term sustainable funding for research and development, particularly outside the USA; and little economic incentive for pharmaceutical companies to develop anticancer drugs adapted for children" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "medicalxpress.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/111777766"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/159947010"] } } }
